Dog allergies and pet insurance: the itch you insure once and claim for every year

The workup a claims reviewer will read, step by step

There is no single blood test that diagnoses an allergic dog, and that fact shapes the claim file. The International Committee on Allergic Diseases of Animals (ICADA) guidelines, published by Hensel and colleagues in BMC Veterinary Research in 2015, describe the diagnosis as a process of exclusion: fleas first, then other parasites such as mites, then bacterial and yeast skin infections, then a reaction to food. Only once those are dealt with is atopic dermatitis a clinical diagnosis. The guidelines add that allergy tests should be used only after that diagnosis has been made, with the main purpose of identifying allergens to avoid or to treat with allergen immunotherapy.

Read as an insurance document, that sequence produces a run of separate invoices over several months, each with its own diagnosis line. A reviewer sees skin scrapings, then cytology for staphylococcal pyoderma or Malassezia yeast, then perhaps a culture, then an eight-week diet trial, and only at the end a word like "atopy". Every one of those earlier lines is a dated sign of the same condition, which is why the first invoice matters more than the last.

Steps and the 8-week minimum come from the ICADA guidelines; the invoice lines and insurance questions are the editors' mapping, not a treatment protocol.

One more detail in the guidelines matters for timing. Among Favrot's criteria, the clinical checklist the guidelines use, is age at onset under three years. Atopic dogs tend to start young, which is often inside the first policy year and sometimes before the policy exists at all.

One condition or five: how linking wording reaches ears, hot spots and pyoderma

Owners tend to think of a puppy's ear infection, a summer hot spot and a later allergy diagnosis as three separate events. Policy forms are written to see them as one condition with an early start date, and they do it with three kinds of wording.

The first is the related-condition clause. Spot's Arizona sample counts as pre-existing any condition "related to, secondary, or resultant from" a pre-existing one. MetLife's sample form PET21-01-V reaches the same place through signs: a condition is pre-existing if the pet showed signs or symptoms "consistent with" the illness before coverage began. Neither form needs an allergy diagnosis on file; an ear treated for yeast before enrollment is enough of a sign if a reviewer reads it as allergic in origin.

The second is a wide definition of a symptom. Spot defines one as any change in health, function, behavior or appearance, including changes "that did not require treatment" at the time. A note that a puppy was licking its feet at the vaccination visit is, on that definition, a recorded symptom.

The third is the most direct, and it appears in Figo's multi-state dog sample. Figo defines a Dermatological Condition as a skin illness that includes ear infections and skin lumps from irritation or infection, then writes a special rule for it: if a dog showed clinical signs of any dermatological condition before the end of the waiting period, it must be free of any dermatological condition for twelve consecutive months before any of them can be covered again. That groups the ears, the paws and the coat into one bucket. One ear infection before enrollment can hold the whole skin category out of cover for at least a year.

Single-state sample forms and insurer pages; your declarations page and state form control. The readings apply the published wording to an invented history and are not coverage decisions.

None of these documents says an ear infection is always allergic. Plenty of ear infections are not, and the insurer has to read the record to decide. But the direction of travel is clear: the more skin and ear entries a dog has before its start date, the more likely the allergy that follows will be dated back to them. The pre-existing conditions guide covers the general definition; the ear-specific claim path, including the two-ears question, is in the ear infection claim guide.

Why the cured-condition route rarely rescues an allergic dog

Several insurers let a pre-existing condition back into cover once it has been cured and quiet for a set period. It is a real benefit for a one-off bladder infection or a healed wound. For allergy it almost never works, and the reason is in the definitions rather than in the dog.

Spot's sample allows a cured pre-existing condition to return after 180 days free of treatment and symptoms, then says the route does not apply to chronic conditions. Lemonade's explainer names allergies among the chronic conditions it says cannot be cured. Fetch puts allergies on its incurable list while putting ear infections and hot spots on its curable one, and its curable route has a second trap: the dog must go a full policy year without signs or treatment, either the first year or the second, and a condition that returns during the second year becomes a permanent exclusion. Figo's twelve-month rule for skin requires the dog to be free of every dermatological condition, not only the original one.

The result is a timing problem that owners can see coming. A dog whose ears flare every spring will rarely string together twelve clean months, so an early ear record that might have qualified as curable keeps restarting its own clock. If the insurer then links the ears to an allergy diagnosis, the curable route closes entirely, because the condition it is now attached to is chronic by definition.

The prescription lines, and which sample forms pay each one

Once an allergy is covered, the cost is mostly in recurring line items rather than in one big bill. The forms differ more on these lines than on the condition itself. Drug names below appear only as claim lines, the way they print on an invoice; nothing here suggests what a dog should be given.

Two regulatory facts change how the medication lines are read. Zoetis states that Apoquel (oclacitinib tablets) was the first Janus kinase inhibitor approved by the US Food and Drug Administration for veterinary use. Its injectable allergy product, Cytopoint, was licensed by the US Department of Agriculture in December 2016, after a conditional license in August 2015, because it is a monoclonal antibody, a biologic, rather than a drug. Both Spot's and Figo's samples define covered medication as one approved by the FDA. A USDA-licensed injection does not fit that wording word for word, and none of the forms read here names it. MetLife's sample is broader: its medication benefit lists injections and take-home medications, prescription or over the counter, as long as a vet prescribed them. That does not mean it is refused; injections are usually billed as treatment. It means the classification is a question to put to the insurer in writing before the first claim, not after.

Each insurer's own sample form, quoted in short. Sample forms are single-state examples, and the Trupanion form is a 2011 edition kept for its wording on food and supplements; current terms may differ. "Not named" means the document is silent, which is not the same as excluded.

Read the table by column, not by row. A dog on daily tablets and medicated baths is a cheap claim to process on one form and a partly unpaid one on another, and the difference is not visible on a quote page. If an allergy is already part of a dog's life, the medication and grooming exclusions are worth reading before the premium.

The eight-week diet trial most forms were not written for

The ICADA guidelines say a strict elimination diet trial should be fed exclusively for a minimum of eight weeks, and that a dog not responding to a commercial elimination diet may be tried on a home-cooked one. Food is where policy wording is most restrictive, so this single step can be paid in full, paid in part, or not at all.

Spot's sample covers prescription pet food to treat a covered condition, but its definition leaves out homemade diets and its exclusions list limited ingredient diets, even if prescribed, along with food used beyond resolution of symptoms for prevention or general health maintenance. Read together, a prescription hydrolysed diet during the trial fits the cover; a home-cooked trial diet does not; and the same food continued once the itch has settled can be argued to be maintenance. AKC's form excludes all diets and pet food unless a prescription diet is the sole treatment of a covered condition, which a trial run alongside other treatment may not be. Figo's sample excludes all foods, prescribed or not, except for up to $250 a policy term when food is the sole treatment and the Office Visit and Exam Fees endorsement is on the policy. MetLife's sample covers food that can only be bought from a veterinary provider with a prescription.

Trupanion's 2011 form is the oddest fit, and the most precise. It paid only the incremental cost of a therapeutic food, the difference over ordinary food, for up to two months of feeding, then offered a premium discount if the food became the long-term diet. Two months is close to the eight weeks the guidelines set. That edition is old and the current form may read differently, but it shows the shape of the question to ask: does the policy pay the trial, the maintenance diet, or neither? Beyond allergies, the prescription food coverage guide runs a full year of a hydrolyzed diet for a 50-pound dog through six sample contracts, from the Figo $250 allowance to cover with no food cap.

Five years of one allergy under two deductible designs

Most accident-and-illness policies use an annual deductible, which resets every policy year. Trupanion uses a lifetime per-condition deductible: its own page says the deductible is applied once to any given condition during the pet's lifetime, and a new deductible applies only when a new condition appears. For a one-off injury the two designs behave the same. For a condition that is claimed every year they pull apart, and the gap is easy to compute.

The inputs below are invented and round. Year one, the workup year, costs $1,600. Each later year costs $1,000, the top of the $200 to $1,000 average annual allergy treatment range that Lemonade publishes. Both policies carry a $500 deductible and 80 percent reimbursement, and no limit is reached. Premiums are left out on purpose, because the two designs are priced differently and this chart only shows the deductible mechanics.

The $1,600 gap has a simple source: the annual design charges the $500 deductible four more times, and each time the owner keeps 80 percent of it as a cost the insurer would otherwise have paid, so 4 x $500 x 80% = $1,600. That holds whatever the yearly bill is, as long as each year's bill is above the deductible. In a mild year with a bill below $500, the annual design pays nothing at all, while the per-condition design would still pay 80 percent of it. Neither fact says which policy is cheaper overall, because the premium difference over five years can be larger or smaller than $1,600; the deductible and limits guide sets out how the levers trade against premium.

There is a twist that runs against the previous sections. Under an annual deductible, having an ear infection counted as part of the allergy costs nothing extra in deductible, and the linking question only matters at enrollment. Under a per-condition deductible, linking can help: if each ear flare is treated as its own new condition, each could carry its own deductible, while if the ears are counted as part of the allergy, one deductible covers the lot. The same record that hurts a dog at enrollment can save money once it is insured, so it is worth asking how an insurer with a per-condition deductible groups secondary skin and ear infections.

Limits that run down, and renewals that rewrite the file

An annual limit resets each year, so a steady allergy bill of a few hundred dollars rarely tests it. A per-incident or per-condition limit is a different matter. AKC's North Carolina form defines an incident as a specifically identifiable illness that may include related diagnoses, says a recurring or chronic incident counts as one incident, and adds that per-incident limits do not reset at renewal. For an allergy, a per-incident limit on that form is in practice a lifetime pool for the condition, drawn down by every year of tablets and rechecks. On a policy with that structure, the limit to compare is the one attached to the condition, not the annual figure printed at the top of the quote.

Renewal is the other moving part. Trupanion's 2011 form said coverage and premium would not change because of a pet's own claims experience, while AKC's form reserves the right to change premium, deductibles and terms at renewal. Whether a renewal can add a new exclusion for a condition the dog has already claimed is a question to ask in writing. The likelier change is in price: allergy claims feed the same cost trend that pushes every premium up, and the renewal increase guide breaks down where an increase comes from.

A lapse is worse than either. Lemonade's explainer walks through a dog whose skin allergy was covered, whose owner paused the policy during a healthy spell, and whose allergy was then treated as pre-existing under the new policy. That is the general rule on every form read here. AKC's 365-day route is the only exception in this set, and it pays only for treatment after a year of continuous cover. For an allergic dog, continuous cover is worth more than almost any feature on the quote, which is the case the switching guide makes for keeping the old policy until the new one is settled.

How the skin file differs from breed to breed

Skin disease is common in dogs generally, but the claim file looks different by breed, and the UK VetCompass studies carried on this site's breed profiles show where. They are UK primary-care records, so the percentages describe diagnoses in that population, not US insurance claims.

In French Bulldogs, the VetCompass breed study found otitis externa in 9.4 percent of 2,781 dogs in 2016, with allergic skin disorder at 7.68 times the odds of other breeds and food hypersensitivity at 6.96. That is the profile most likely to arrive at enrollment with an ear or skin note already on the chart, and the breed with the most to lose from Figo-style grouping of all skin conditions.

In Labrador Retrievers, otitis externa was the single most common disorder at 10.4 percent, and coat colour moved it sharply: 12.8 percent of black dogs, 17.0 percent of yellow and 23.4 percent of chocolate. Hot spots followed the same order at 1.1, 1.6 and 4.0 percent. For a chocolate Labrador, the repeat ear claim is close to the expected case, so the deductible design in the chart above is the main lever.

In English Bulldogs, the skin file is about folds and feet as much as allergy: skin fold dermatitis in 6.7 percent of 2,662 dogs, interdigital cysts at 12.96 times the odds, pyoderma at 3.50 and otitis externa in 16.2 percent. Those are infections that are often secondary, which is exactly what related-condition wording is built to catch.

In Shih Tzus, the 2024 VetCompass study of 2,423 dogs found skin disorders were the most common disorder group at 16.6 percent, ahead of dental and eye disease, with a median age of 4.3 years; atopic dermatitis itself was recorded in 2.2 percent. The breed profile leads with eyes and airways, but on these numbers the most likely claim category is the skin. Golden Retrievers carry allergies, hot spots and ear problems on their profile as steady mid-size claims, sitting alongside a cancer risk that makes the annual limit the bigger worry later in life.

Matching the policy structure to a dog that will itch for life

No single design wins for every allergic dog. The right structure depends on what is already on the chart and how the bill is likely to behave. These are the patterns the documents above point to, not recommendations of any insurer.

Whatever the structure, get the dog's full record from every clinic it has seen before applying, and read it the way a reviewer will. The cheapest point to settle these questions is before the first premium, not on the first claim. More condition-by-condition claim files are on the conditions hub.